{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["262(2)"],"submitter":["Merkhassine M"],"pubmed_abstract":["Glucagon plays a central role in amino acid (AA) homeostasis. The dog is an established model of glucagon biology, and recently, metabolomic changes in people associated with glucagon infusions have been reported. Glucagon also has effects on the kidney; however, changes in urinary AA concentrations associated with glucagon remain under investigation. Therefore, we aimed to fill these gaps in the canine model by determining the effects of glucagon on the canine plasma metabolome and measuring urine AA concentrations. Employing two constant rate glucagon infusions (CRI) - low-dose (CRI-LO: 3 ng/kg/min) and high-dose (CRI-HI: 50 ng/kg/min) on five research beagles, we monitored interstitial glucose and conducted untargeted liquid chromatography-tandem mass spectrometry (LC-MS/MS) on plasma s"],"journal":["The Journal of endocrinology"],"pagination":["e240051"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11301426"],"repository":["biostudies-literature"],"pubmed_title":["Glucagon infusion alters the circulating metabolome and urine amino acid excretion in dogs."],"pmcid":["PMC11301426"],"pubmed_authors":["Bennett LL","Morse B","Loftus JP","Frederick CE","Peng SA","Cummings BP","Coch RW","Merkhassine M"],"additional_accession":[]},"is_claimable":false,"name":"Glucagon infusion alters the circulating metabolome and urine amino acid excretion in dogs.","description":"Glucagon plays a central role in amino acid (AA) homeostasis. The dog is an established model of glucagon biology, and recently, metabolomic changes in people associated with glucagon infusions have been reported. Glucagon also has effects on the kidney; however, changes in urinary AA concentrations associated with glucagon remain under investigation. Therefore, we aimed to fill these gaps in the canine model by determining the effects of glucagon on the canine plasma metabolome and measuring urine AA concentrations. Employing two constant rate glucagon infusions (CRI) - low-dose (CRI-LO: 3 ng/kg/min) and high-dose (CRI-HI: 50 ng/kg/min) on five research beagles, we monitored interstitial glucose and conducted untargeted liquid chromatography-tandem mass spectrometry (LC-MS/MS) on plasma s","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Aug","modification":"2026-06-01T19:35:03.757Z","creation":"2025-04-06T11:29:55.667Z"},"accession":"S-EPMC11301426","cross_references":{"pubmed":["38814331"],"doi":["10.1530/JOE-24-0051"]}}